News
Personalized expert instruction informed by artificial intelligence (AI) data improved surgical performance and skill ...
A study finds 70 years may be a key cutoff for oxaliplatin benefit in stage III colorectal cancer, with no survival advantage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results